PortfoliosLab logoPortfoliosLab logo
MIST vs. UNCY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MIST vs. UNCY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Milestone Pharmaceuticals Inc. (MIST) and Unicycive Therapeutics Inc (UNCY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MIST achieves a -45.05% return, which is significantly lower than UNCY's -13.17% return.


MIST

1D
-3.48%
1M
-15.91%
6M
-41.88%
YTD
-45.05%
1Y
-22.38%
3Y*
-29.52%
5Y*
-27.91%
10Y*
ALL TIME*
-30.63%

UNCY

1D
-5.47%
1M
-12.57%
6M
-16.08%
YTD
-13.17%
1Y
19.29%
3Y*
-24.41%
5Y*
-28.91%
10Y*
ALL TIME*
-36.58%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.41M$1.40M$1.91M
$4.23M$6.09M$9.40M

MIST vs. UNCY - Yearly Performance Comparison


2026 (YTD)20252024202320222021
MIST
Milestone Pharmaceuticals Inc.
-45.05%-14.41%41.32%-57.83%-39.54%19.74%
UNCY
Unicycive Therapeutics Inc
-13.17%-27.35%-8.47%60.69%-73.79%-58.80%

Correlation

The correlation between MIST and UNCY is 0.33, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.33

Correlation (3Y)
Balances recent behavior with more history.

0.20

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.15

Correlation (All Time)
Calculated using the full available price history since Jul 12, 2021

0.15

The correlation between MIST and UNCY shifts across timeframes, from 0.15 (5 years) to 0.33 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

MIST:

$95.34M

UNCY:

$133.77M

EPS

MIST:

-$0.45

UNCY:

-$0.29

PB Ratio

MIST:

4.01

UNCY:

31.77

Total Revenue (TTM)

MIST:

$1.78M

UNCY:

$0.00

Gross Profit (TTM)

MIST:

$1.75M

UNCY:

$0.00

EBITDA (TTM)

MIST:

-$63.04M

UNCY:

-$35.07M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MIST vs. UNCY — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

MIST
MIST Risk / Return Rank: 3131
Overall Rank
MIST Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
MIST Sortino Ratio Rank: 3232
Sortino Ratio Rank
MIST Omega Ratio Rank: 3232
Omega Ratio Rank
MIST Calmar Ratio Rank: 3232
Calmar Ratio Rank
MIST Martin Ratio Rank: 3232
Martin Ratio Rank

UNCY
UNCY Risk / Return Rank: 5555
Overall Rank
UNCY Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
UNCY Sortino Ratio Rank: 5454
Sortino Ratio Rank
UNCY Omega Ratio Rank: 5656
Omega Ratio Rank
UNCY Calmar Ratio Rank: 5353
Calmar Ratio Rank
UNCY Martin Ratio Rank: 5858
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

MIST vs. UNCY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Milestone Pharmaceuticals Inc. (MIST) and Unicycive Therapeutics Inc (UNCY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MISTUNCYDifference
Sharpe ratioReturn per unit of total volatility

-0.53

Sortino ratioReturn per unit of downside risk

-0.85

Omega ratioGain probability vs. loss probability

1.00

1.12

-0.12

Calmar ratioReturn relative to maximum drawdown

-0.36

0.34

-0.70

Martin ratioReturn relative to average drawdown

-0.64

1.05

-1.70

MIST vs. UNCY - Sharpe Ratio Comparison

The current MIST Sharpe Ratio is -0.33, which is lower than the UNCY Sharpe Ratio of 0.20. The chart below compares the historical Sharpe Ratios of MIST and UNCY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MIST vs. UNCY - Drawdown Comparison

The maximum MIST drawdown since its inception was -97.60%, roughly equal to the maximum UNCY drawdown of -95.97%. Use the drawdown chart below to compare losses from any high point for MIST and UNCY.


Loading charts...

Drawdown Indicators


MISTUNCYDifference

Max Drawdown

Largest peak-to-trough decline

-97.60%

-95.97%

-1.63%

Max Drawdown (1Y)

Largest decline over 1 year

-65.76%

-45.21%

-20.55%

Max Drawdown (3Y)

Largest decline over 3 years

-81.18%

-86.82%

+5.64%

Max Drawdown (5Y)

Largest decline over 5 years

-93.13%

-92.26%

-0.87%

Current Drawdown

Current decline from peak

-95.91%

-91.44%

-4.47%

Average Drawdown

Average peak-to-trough decline

-78.60%

-83.05%

+4.45%

Ulcer Index

Depth and duration of drawdowns from previous peaks

36.42%

14.72%

+21.70%

Volatility

MIST vs. UNCY - Volatility Comparison

The current volatility for Milestone Pharmaceuticals Inc. (MIST) is 18.08%, while Unicycive Therapeutics Inc (UNCY) has a volatility of 21.35%. This indicates that MIST experiences smaller price fluctuations and is considered to be less risky than UNCY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MISTUNCYDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.08%

21.35%

-3.27%

Volatility (6M)

Calculated over the trailing 6-month period

55.16%

71.93%

-16.77%

Volatility (1Y)

Calculated over the trailing 1-year period

70.52%

78.88%

-8.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

78.04%

118.98%

-40.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

104.47%

120.08%

-15.61%

Dividends

MIST vs. UNCY - Dividend Comparison

Neither MIST nor UNCY has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

MIST vs. UNCY - Financials Comparison

This section allows you to compare key financial metrics between Milestone Pharmaceuticals Inc. and Unicycive Therapeutics Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


MIST and UNCY have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

UNCY has higher volatility (21.35%) compared to MIST (18.08%). In terms of maximum drawdown, MIST dropped -97.60% vs UNCY's -95.97%.

UNCY currently has the higher Sharpe Ratio (0.20 vs -0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MIST and UNCY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer